MAS Stock Analysis: Masco | NYSE
Building Products & Equipment | NYSE, USA | Market Cap: 14.452m USD | 12M Return: 1.4% | US5745991068 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 148M
EPS Trend: 78.5%
Qual. Beats: 2
Rev. Trend: -93.7%
Qual. Beats: -1
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Masco Corporation is a U.S.-based manufacturer of home improvement and building products, operating through two core segments: Plumbing Products and Decorative Architectural Products. The Plumbing Products segment manufactures faucets, showerheads, valves, bath and shower enclosures, spas, water filtration systems, and PEX tubing under a wide portfolio of brands including DELTA, BRIZO, HANSGROHE, KRAUS, HOT SPRING, and BRASSCRAFT, with products sold both under company-owned labels and private label arrangements.
The Decorative Architectural Products segment produces paints, primers, stains, and specialty coatings (under the BEHR and KILZ brands), as well as cabinet hardware, functional hardware, and bath/shower accessories under LIBERTY and FRANKLIN BRASS. Products reach customers through home centers, mass merchandisers, online retailers, wholesalers, distributors, plumbing contractors, remodelers, and OEMs, giving the company exposure to both new construction and home repair and remodeling demand.
Founded in 1929 and headquartered in Livonia, Michigan, Masco sits within the GICS Industrials sector and Building Products sub-industry. The building products industry is closely tied to residential housing starts, renovation cycles, and consumer spending on home improvement, with major brands typically distributed through large home improvement retailers that act as key channel partners.
- Higher mortgage rates slow existing home sales and remodeling demand
- Behr paint pricing power offsets raw material cost inflation
- Plumbing segment margins hold up despite softer new construction volumes
| Net Income: 885.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.27 > 0.02 and ΔFCF/TA 11.58 > 1.0 |
| NWC/Revenue: 18.67% < 20% (prev 17.17%; Δ 1.50% < -1%) |
| CFO/TA 0.30 > 3% & CFO 1.62b > Net Income 885.0m |
| Net Debt (3.19b) to EBITDA (1.49b): 2.14 < 3 |
| Current Ratio: 1.86 > 1.5 & < 3 |
| Outstanding Shares: last quarter (198.8m) vs 12m ago -5.81% < -2% |
| Gross Margin: 36.93% > 18% (prev 36.27%; Δ 0.66% > 0.5%) |
| Asset Turnover: 142.6% > 50% (prev 144.9%; Δ -2.34% > 0%) |
| Interest Coverage Ratio: 13.01 > 6 (EBIT TTM 1.34b / Interest Expense TTM 103.0m) |
| A: 0.26 (Total Current Assets 3.07b - Total Current Liabilities 1.65b) / Total Assets 5.40b |
| B: -0.16 (Retained Earnings -849.0m / Total Assets 5.40b) |
| C: 0.25 (EBIT TTM 1.34b / Avg Total Assets 5.34b) |
| D: -0.07 (Book Value of Equity -365.0m / Total Liabilities 5.52b) |
| Altman-Z'' = 2.83 = A |
| DSRI: 1.02 (Receivables 1.34b/1.32b, Revenue 7.62b/7.66b) |
| GMI: 0.98 (GM 36.27% / 36.93%) |
| AQI: 0.92 (AQ_t 0.16 / AQ_t-1 0.18) |
| SGI: 0.99 (Revenue 7.62b / 7.66b) |
| TATA: -0.14 (NI 885.0m - CFO 1.62b) / TA 5.40b) |
| Beneish M = -3.09 (Cap -4..+1) = AA |
As of August 30, 2026, the stock is trading at USD 73.25 with a total of 1,314,045 shares traded. Over the past week, the price has changed by +0.38%, over one month by -9.85%, over three months by +4.08% and over the past year by +1.44%.
Current recommended Stop Loss: 70.10 (which is 4.3% or 1.5 ATR below the current price).
Masco has received a consensus analysts rating of 3.67. Therefore, it is recommended to hold MAS.
- StrongBuy: 7
- Buy: 1
- Hold: 12
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 80.7 | 10.1% |
P/E Trailing = 16.8871
P/E Forward = 17.8253
P/S = 1.8966
P/B = 160.2462
P/EG = 1.897
Revenue TTM = 7.62b USD
EBIT TTM = 1.34b USD
EBITDA TTM = 1.49b USD
Long Term Debt = 3.25b USD (from longTermDebt, last quarter)
Short Term Debt = 2.00m USD (from shortTermDebt, last quarter)
Debt = 3.74b USD (from shortLongTermDebtTotal, last quarter) + Leases 246.0m
Net Debt = 3.19b USD (calculated: Debt 3.74b - CCE 548.0m)
Enterprise Value = 17.6b USD (14.5b + Debt 3.74b - CCE 548.0m)
Interest Coverage Ratio = 13.01 (Ebit TTM 1.34b / Interest Expense TTM 103.0m)
EV/FCF = 12.14x (Enterprise Value 17.6b / FCF TTM 1.45b)
FCF Yield = 8.24% (FCF TTM 1.45b / Enterprise Value 17.6b)
FCF Margin = 19.07% (FCF TTM 1.45b / Revenue TTM 7.62b)
Net Margin = 11.61% (Net Income TTM 885.0m / Revenue TTM 7.62b)
Gross Margin = 36.93% ((Revenue TTM 7.62b - Cost of Revenue TTM 4.81b) / Revenue TTM)
Gross Margin QoQ = 43.57% (prev 35.77%)
Tobins Q-Ratio = 3.27 (Enterprise Value 17.6b / Total Assets 5.40b)
Interest Expense / Debt = 2.75% (Interest Expense 103.0m / Debt 3.74b)
Taxrate = 24.07% (297.0m / 1.23b)
NOPAT = 1.02b (EBIT 1.34b * (1 - 24.07%))
Current Ratio = 1.86 (Total Current Assets 3.07b / Total Current Liabilities 1.65b)
Debt / Equity = -10.24 (negative equity) (Debt 3.74b / totalStockholderEquity, last quarter -365.0m)
Debt / EBITDA = 2.14 (Net Debt 3.19b / EBITDA 1.49b)
Debt / FCF = 2.20 (Net Debt 3.19b / FCF TTM 1.45b)
Total Stockholder Equity = -91.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 16.56% (Net Income 885.0m / Total Assets 5.40b)
RoE = -972.5% (negative equity) (Net Income TTM 885.0m / Total Stockholder Equity -91.0m)
RoCE = 42.49% (EBIT 1.34b / Capital Employed (Equity -91.0m + L.T.Debt 3.25b))
RoIC = 30.14% (NOPAT 1.02b / Invested Capital 3.38b)
WACC = 8.20% (E(14.5b)/V(18.2b) * Re(9.78%) + D(3.74b)/V(18.2b) * Rd(2.75%) * (1-Tc(0.24)))
Discount Rate = 9.78% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -98.44 | Cagr: -4.80%
[DCF] Terminal Value 77.97% ; FCFF base≈1.20b ; Y1≈1.37b ; Y5≈2.02b
[DCF] Fair Price = 137.8 (EV 30.4b - Net Debt 3.19b = Equity 27.2b / Shares 197.2m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 78.53 | EPS CAGR: 3.92% | SUE: 3.48 | # QB: 2
Revenue Correlation: -93.70 | Revenue CAGR: -2.05% | SUE: -2.16 | # QB: -1
EPS current Quarter (2026-09-30): EPS=1.03 | Chg30d=-2.54% | Revisions=-74% | Analysts=19
EPS current Year (2026-12-31): EPS=4.53 | Chg30d=+6.11% | Revisions=+87% | GrowthEPS=+14.4% | GrowthRev=+1.3%
EPS next Year (2027-12-31): EPS=4.66 | Chg30d=-0.94% | Revisions=-35% | GrowthEPS=+2.8% | GrowthRev=+2.7%
[Analyst] Revisions Ratio: -2% (up=26, down=27)